News

Poor Outcomes Reported for Many Medicare Stroke Patients

Publish date: December 16, 2010

 

FROM STROKE

Several investigators cited financial ties to manufacturers of drugs for ischemic stroke.

Pages

Recommended Reading

Bevacizumab Combinations Effective in Phase II Glioblastoma Trials
MDedge Internal Medicine
Device for Glioblastoma May Offer Advantage Over Chemo
MDedge Internal Medicine
FDA Rejects Approval for Epilepsy Drug Ezogabine
MDedge Internal Medicine
New Guidelines Issued on Stroke Prevention
MDedge Internal Medicine
Subspecialty Created to Improve Epilepsy Care
MDedge Internal Medicine
Brief Decline in Quality of Life Seen After Brain Radiotherapy
MDedge Internal Medicine
Blacks May Be More Severely Affected by Parkinsonism Than Whites
MDedge Internal Medicine
Vitamin D Deficiency Doesn't Raise Stroke Risk in Blacks
MDedge Internal Medicine
Asymptomatic Atrial High-Rate Episodes Boost Stroke Risk
MDedge Internal Medicine
Neurostimulation Poised to Take On Tough Seizures
MDedge Internal Medicine